TFeasibility and favorable short term outcome with respect to complications has been already convincingly shown for robotic-assisted radical hysterectomy. With respect to oncological safety there are at present only few studies mainly retrospectively. However, these seem to confirm the data from classical laparoscopic surgery that oncological outcome is not impaired by minimal-invasive surgery. Since robotic-assisted radical hysterectomy is in fact technically supported laparoscopic radical hysterectomy it is reasonable to assume that results are at least equal compared to the classical laparoscopic approach.